# Russia/Ukraine Suppression of Ovarian Activity Study

> **NCT02550977** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 91 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Gestodene/EE Patch (BAY86-5016)

## Key facts

- **NCT ID:** NCT02550977
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-18
- **Primary completion:** 2016-07-15
- **Final completion:** 2016-08-15
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550977, "Russia/Ukraine Suppression of Ovarian Activity Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02550977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*